How much time should I budget?

About 3 hours total, a working session and a review call. We do the heavy lifting.

What if I only want the roadmap, not the build?

That's the Campaign Repositioning Sprint. Ship it yourself, or upgrade to Done-For-You later.

Do you interview my customers?

Optional. We can mine your call recordings, reviews, and won/lost notes instead.

B2B teams spending $20K+/mo on ads whose demos aren't converting.

Book a 30-minute call. We'll tell you straight if it's a fit.

Where Medcrypt's ads lose the buyer

Medcrypt is running 17 live ads on LinkedIn and Google. Their average fit to their own ideal buyer is 7.8 out of 10, and 2 ads need fixing. Each ad below is one of Medcrypt’s real live creatives, read straight from the ad libraries.

Medcrypt’s live ads, scored against their buyer

FDA just issued its first public cybersecurity warning letter., scored 9/10 against Medcrypt’s ideal buyer. Urgent regulatory news hook with specific enforcement stakes and a free, low-friction CTA lands perfectly on the ICP's fear of enforcement action.
The constraints on medical device security aren’t going away. The cost of gettin, scored 8/10 against Medcrypt’s ideal buyer. Former-FDA credibility and cost-of-compliance framing speak directly to the ICP's pain, though the webinar-clip format softens the urgency versus a direct offer.
Cybersecurity is now a standard line item in QMSR inspections., scored 8/10 against Medcrypt’s ideal buyer. Specific data point from first 100 QMSR inspections creates real urgency for quality and regulatory buyers, with a free readiness CTA that lowers the barrier to act.
Traceable, not just true., scored 7/10 against Medcrypt’s ideal buyer. Inspector-fear hook lands hard, but ISO/IEC standard callouts skew toward quality teams over product security buyers.
We didn’t fix auto safety by telling drivers to be careful. We required crumple , scored 6/10 against Medcrypt’s ideal buyer. Thought-leadership framing builds credibility but stays upstream of the submission-rejection pain the ICP feels daily.
“My last device was approved, so my next one will be.” Not anymore. Under 524B, , scored 8/10 against Medcrypt’s ideal buyer. Direct challenge to a real MDM assumption, 524B table contrast makes the regulatory shift concrete and urgent.
Approval was the start, not the finish., scored 8/10 against Medcrypt’s ideal buyer. 524B postmarket mandate framed as ongoing duty hits the exact post-clearance compliance drift pain, free CTA lowers barrier.
15 deliverables, one connected workflow., scored 9/10 against Medcrypt’s ideal buyer. Blank-page pain, 15 deliverables proof, source-cited output, and demo CTA all land precisely on the regulatory affairs buyer.
In 2014, a physician asked our founder: “Who would ever hack a medical device?” , scored 6/10 against Medcrypt’s ideal buyer. Founder story and breach data build awareness but stop short of connecting threat reality to submission or compliance action.
The most expensive submission is the one you file twice., scored 9/10 against Medcrypt’s ideal buyer. Filing-twice hook targets the single biggest financial fear, FDA-reviewer benchmark framing and free readiness CTA are best-in-class.
Start Your Assessment Today - Get a Free Security Review, scored 7/10 against Medcrypt’s ideal buyer. FDA Readiness and gap analysis match high-intent queries well, but '100% Guaranteed Approval' claim risks credibility with a skeptical regulatory buyer.
Accelerate FDA Approval Now - 100% Guarantee FDA Approval, scored 9/10 against Medcrypt’s ideal buyer. Zero-rejection proof point and free review CTA nail the submission-anxiety buyer perfectly.
MedCrypt, scored 7/10 against Medcrypt’s ideal buyer. Approval guarantee lands well but brand-name headline wastes the prime hook position.
Get a Free Security Review - Build Secure Devices by Design, scored 8/10 against Medcrypt’s ideal buyer. Maturity score and gap analysis deliverables make the free offer concrete and credible for the ICP.
MedCrypt, scored 7/10 against Medcrypt’s ideal buyer. Approval guarantee lands well but brand-name headline wastes the prime hook position.
Medical Device Cybersecurity, scored 8/10 against Medcrypt’s ideal buyer. Three punchy proof points plus Top 50 trust signal make a compelling display banner for the ICP.
Medical Device Cybersecurity, scored 8/10 against Medcrypt’s ideal buyer. Stacked proof points and free review CTA work hard for the submission-focused buyer in display format.

See Medcrypt’s full live-ad board on AdRoast. Every creative scored against their ICP, with the exact fix for each.

Learn the method behind these scores: the AdRoast guides cover how to audit your ads against your ICP and why clicks do not turn into pipeline.